U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07271966) titled 'B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy' on Nov. 26.
Brief Summary: This is a supportive care study to assess the effect of Vitamin B6 supplementation on mood-related side effects of levetiracetam in patients with brain tumors, who have already been prescribed levetiracetam for the prevention of seizures. This study will assess this effect from the perspective of both the patient and the patient's caregiver.
Patients will receive Vitamin B6 as a supplement to take daily for 8 to 12 weeks, in addition to the already prescribed levetiracetam and will undergo study assessments as well as com...